Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons

BACKGROUND: Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in patients with non-valvular atrial fibrillation (AF). We conducted an imputed-placebo analysis with estimates of the proportion of warfarin effect preserved by each non vitamin K antagonist oral anticoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdecchia, Paolo, Angeli, Fabio, Lip, Gregory Y. H., Reboldi, Gianpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067355/
https://www.ncbi.nlm.nih.gov/pubmed/24955573
http://dx.doi.org/10.1371/journal.pone.0100478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067355/
https://www.ncbi.nlm.nih.gov/pubmed/24955573
http://dx.doi.org/10.1371/journal.pone.0100478

Ejemplares similares